The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
Open accessAbstract
Considering the well established role of nonclassical HLA-G class I molecules in inhibiting natural killer (NK) cell function, the consequence of abnormal HLA-G expression in malignant cells should be the escape of tumors from immunosurveillance. To examine this hypothesis, we analyzed HLA-G expression and NK sensitivity in human malignant melanoma cells. Our analysis of three melanoma cell lines and ex vivo biopsy demonstrated that (i) IGR and M74 human melanoma cell lines exhibit a high level of HLA-G transcription with differential HLA-G isoform transcription and protein expression patterns, (ii) a higher level of HLA-G transcription ex vivo is detected in a skin melanoma metastasis biopsy compared with a healthy skin fragment from the same individual, and (iii) HLA-G protein isoforms other than membrane-bound HLA-G1 protect IGR from NK lysis. It thus appears of critical importance to consider the specific role of HLA-G expression in tumors in the design of future cancer immunotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., & DeMars, R. (1990) · Science · doi:10.1126/science.2326636 · Cited by 1,407
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
Rouas-Freiss, N., Gonçalves, R. M.-B., Menier, C., Dausset, J., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11520 · Cited by 701
Self-citationThe activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Ishitani, A., & Geraghty, D. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3947 · Cited by 515
Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells
Pazmany, L., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Reyburn, H. T., & Strominger, J. L. (1996) · Science · doi:10.1126/science.274.5288.792 · Cited by 497
Rouas-Freiss, N., Marchal, R. E., Kirszenbaum, M., Dausset, J., & Carosella, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5249 · Cited by 353
Self-citationMoretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
Cited by
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. J., Makadzange, A., Rowland-Jones, S., Willcox, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431057100 · Cited by 557
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
Moreau, P., Adrian-Cabestre, F., Menier, C., Guiard, V., Gourand, L., Dausset, J., Carosella, E. D., & Paul, P. (1999) · International Immunology · doi:10.1093/intimm/11.5.803 · Cited by 411
Self-citationHLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
Hicklin, D. J., Marincola, F. M., & Ferrone, S. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01451-3 · Cited by 376
HLA-G: from biology to clinical benefits
Carosella, E. D., Moreau, P., LeMaoult, J., & Rouas-Freiss, N. (2008) · Trends in Immunology · doi:10.1016/j.it.2007.11.005 · Cited by 376
Self-citationHLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
CAROSELLA, E. D., MOREAU, P., LE MAOULT, J., LE DISCORDE, M., DAUSSET, J., & ROUAS-FREISS, N. (2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81006-4 · Cited by 371
Self-citationDonadi, E. A., Castelli, E. C., Arnaiz-Villena, A., Roger, M., Rey, D., & Moreau, P. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0580-7 · Cited by 362
Self-citationBeyond the increasing complexity of the immunomodulatory HLA-G molecule
Carosella, E. D., Favier, B., Rouas-Freiss, N., Moreau, P., & LeMaoult, J. (2008) · Blood · doi:10.1182/blood-2007-12-127662 · Cited by 348
Self-citationA Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape
Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H., Melms, A., & Weller, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4772 · Cited by 325
Riteau, B., Rouas-Freiss, N., Menier, C., Paul, P., Dausset, J., & Carosella, E. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5018 · Cited by 324
Self-citationHLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
Le Gal, F.-A., Riteau, B., Sedlik, C., Khalil-Daher, I., Menier, C., Dausset, J., Guillet, J.-G., Carosella, E. D., & Rouas-Freiss, N. (1999) · International Immunology · doi:10.1093/intimm/11.8.1351 · Cited by 316
Self-citationTolerization of dendritic cells by HLA‐G
Ristich, V., Liang, S., Zhang, W., Wu, J., & Horuzsko, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425741 · Cited by 315
Lila, N., Rouas-Freiss, N., Dausset, J., Carpentier, A., & Carosella, E. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201407398 · Cited by 314
Self-citationHLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+T cells
LeMaoult, J., Krawice-Radanne, I., Dausset, J., & Carosella, E. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401922101 · Cited by 314
Self-citationHLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells
Lemaoult, J., Zafaranloo, K., Le Danff, C., & Carosella, E. D. (2005) · The FASEB Journal · doi:10.1096/fj.04-1617fje · Cited by 302
Self-citationAlgarra, I., Garc�a-Lora, A., Cabrera, T., Ruiz-Cabello, F., & Garrido, F. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0517-9 · Cited by 293
HLA-G: At the Interface of Maternal–Fetal Tolerance
Ferreira, L. M. R., Meissner, T. B., Tilburgs, T., & Strominger, J. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.009 · Cited by 291
HLA class I antigen abnormalities and immune escape by malignant cells
Seliger, B., Cabrera, T., Garrido, F., & Ferrone, S. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0404 · Cited by 270
KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential
Faure, M., & Long, E. O. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6208 · Cited by 268
LeMaoult, J., Caumartin, J., Daouya, M., Favier, B., Rond, S. L., Gonzalez, A., & Carosella, E. D. (2007) · Blood · doi:10.1182/blood-2006-05-024547 · Cited by 267
Self-citationThe role of cancer-derived microRNAs in cancer immune escape
Yi, M., Xu, L., Jiao, Y., Luo, S., Li, A., & Wu, K. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00848-8 · Cited by 221
Kailayangiri, S., Altvater, B., Spurny, C., Jamitzky, S., Schelhaas, S., Jacobs, A. H., Wiek, C., Roellecke, K., Hanenberg, H., Hartmann, W., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1250050 · Cited by 104
Human leukocyte immunoglobulin-like receptors in health and disease
Redondo-García, S., Barritt, C., Papagregoriou, C., Yeboah, M., Frendeus, B., Cragg, M. S., & Roghanian, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1282874 · Cited by 53
Metadata
- Authors
- Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F. A., Avril, M. F., Dausset, J., Guillet, J. G., & Carosella, E. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-04-14
- Volume
- 95
- Issue
- 8
- Pages
- 4510-4515
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2160048269
- Cited by
- 432
- References
- 29
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.